Contact Dermatitis Market

The total diagnosed prevalent population of Contact Dermatitis in the 7MM was 43,359,201 in 2017. With around 13,786,942 cases in 2017 the United States accounted for the highest number of diagnosed prevalent cases among the seven major markets.

In 2017, the market size of Contact Dermatitis was found to be USD 7,831 Million in seven major markets, which is expected to increase during the forecast period 2017-2030.

The key pharma companies in the Contact Dermatitis Market include Edesa Biotech, Hapten Sciences and many others.

For more detailed information on Contact Dermatitis Market, visit: https://www.delveinsight.com/report-store/contact-dermatitis-market